According to comparative trials, TCG has been shown to provide higher and more steady degrees of platelet aggregation inhibition and a favorable trend in lowering the risk of myocardial infarction compared to clopidogrel without elevating the risk of severe bleeding.
← all excerpts
Preparation and Evaluation of a Self-Emulsifying Drug Delivery System for Improving the Solubility and Permeability of Ticagrelor.
1
—
—